Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/07/2007CN1923180A Meglumine cyclic adenosine for injecta and its preparing process
03/07/2007CN1923179A Slow release agent for preventing and treating rabbit and chicken coccidiosis and chicken leucocytozoonosisin and preparing method thereof
03/07/2007CN1923178A Oleanolic acid liposome preparation, freeze dried powder injecta thereof and its preparation
03/07/2007CN1923177A Chlorhydric acid tranditerol aerosol
03/07/2007CN1923176A Oil-in-water baicalin nano-milk oral liquid and its preparing process
03/07/2007CN1923174A Anti-cancer slow release injection comprising anticancer antibiotics
03/07/2007CN1923173A Anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof
03/07/2007CN1923172A Drug slow release agent comprising anticancer antibiotics and booster thereof
03/07/2007CN1923171A Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof
03/07/2007CN1923170A Imiquimod turbid liquor and gelling agent thereof
03/07/2007CN1923169A Water aqua containing clindamycin for treating acne
03/07/2007CN1923168A External use plaster for treating acute jerk contused wound
03/07/2007CN1923166A Carbediolo controlled release formulation
03/07/2007CN1923042A New pattern health-care food
03/07/2007CN1303107C Crystalline mixtures of partial methyl ethers of beta cyclodextrin and related compounds
03/07/2007CN1303098C Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine
03/07/2007CN1303097C Japanese polygala saponin kind compound and aglucon, total saponin and total aglucon and its application in medicine
03/07/2007CN1303094C Improved method for preparing anti-parasite preparation
03/07/2007CN1303092C Process for preparing high purity breviscapine B raw material medicine
03/07/2007CN1303090C Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
03/07/2007CN1303089C Crystalline form of Adefovir dipivoxil and preparing process thereof
03/07/2007CN1303086C Compound of dual functional esterified prodrug of Cefetamet, and oral preparation
03/07/2007CN1303085C C6- and C9-substituted isoxazoline derivatives and their use as anti-depressants
03/07/2007CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents
03/07/2007CN1303082C 3-phenyl-3.7-diazobicyclo [3,3,1] nonane compound and its preparation method and medicine containing it
03/07/2007CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
03/07/2007CN1303073C Substituted triazolone benzyl amine triazole antifungal compounds and method for preparing same
03/07/2007CN1303072C 7-oxo pyridopyrimidines
03/07/2007CN1303069C Acutumine and acutumine compound, synthesis and use thereof
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/07/2007CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
03/07/2007CN1303065C Ambroxol cysteine analogs salt and their preparation process and use thereof
03/07/2007CN1303059C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
03/07/2007CN1302815C Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues
03/07/2007CN1302810C Optic nerve protecting agents containing alpha1 receptor blocker as the active ingredient
03/07/2007CN1302809C Nanometer granule prepn of bufanin albumin and its prepn process
03/07/2007CN1302783C Oral taking preparation for aesthetic health care and preparation method
03/07/2007CN1302782C Jixitabing hydrochloride solution type injection agent
03/07/2007CN1302781C Target magnetic nano drug for treating leucosis and producing method thereof
03/07/2007CN1302780C Use of alkyl phosphocholines in preparation of medicine used with antitumor medicaments
03/07/2007CN1302779C Pharmaceutical preparation comprising abacavir and alovudine and use thereof
03/07/2007CN1302778C Dispersible tablet of acetazolamide and its preparation method
03/07/2007CN1302777C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
03/07/2007CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation
03/07/2007CN1302775C Use of ligustilide for prevention and treatment of atherosclerosis
03/07/2007CN1302774C Efferverscent tablets containing troxerutin and their preparation
03/07/2007CN1302773C Method for preparing nanometer suspension of DHA
03/07/2007CN1302772C Orally disintegrated sodium ferulate tablet and its prepn process
03/07/2007CN1302771C 2-(4-isobutylphenyl) propionic acid medicinal composition
03/07/2007CN1302770C Gel of chlormethine hydrochloride and preparing method
03/07/2007CN1302769C Aqueous injection of curcuma oil extract and preparation process and use
03/07/2007CN1302768C Physiologically active agents containing vicinal dithioglycols and use therof in various branches of economy
03/07/2007CN1302767C Apoplexy treating injection
03/06/2007USRE39502 Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
03/06/2007US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function
03/06/2007US7186865 Optically active 1-(fluoro-, trifluoromethyl-or trifluoromethoxy-substituted phenyl) alkylamine n-monoalkyl derivatives and process for producing same
03/06/2007US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma
03/06/2007US7186863 Sertraline compositions
03/06/2007US7186859 Uses for amino acid anticonvulsants
03/06/2007US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release
03/06/2007US7186849 C7 ester substituted taxanes
03/06/2007US7186846 Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed therein
03/06/2007US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents
03/06/2007US7186842 Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
03/06/2007US7186841 Antiinflammation agents
03/06/2007US7186840 Quinoline derivatives as anti-inflammatory agents
03/06/2007US7186839 Extraction uisng aqueous solution containing metal compound
03/06/2007US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
03/06/2007US7186836 Thienyl compounds
03/06/2007US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
03/06/2007US7186830 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
03/06/2007US7186826 Phosphorus-containing compounds and uses thereof
03/06/2007US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors
03/06/2007US7186824 Incorporating trehalose into an edible aqueous system containing alpha glucosyl hesperidin or catechin or both followed by sterilization
03/06/2007US7186818 DNA encoding soluble variants of human OX2 receptors
03/06/2007US7186803 Human vanilloid receptor VR3 protein
03/06/2007US7186756 Steroid derivatives and use thereof as medicaments
03/06/2007US7186755 Carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and ethanol, isopropanol or diethylene glycol monoethyl ether as a solvent
03/06/2007US7186754 Use of creatine or creatine compounds for skin preservation
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186751 anticarcinogenic agents comprising a mixture of taxol, solubilizers, stabilizers and anhydrous ethanol, having superior solubility, stability, bioavailability and side effect reduction
03/06/2007US7186750 Optically active maleimide derivatives, optically active polymaleimide derivatives, process for their production, separating media comprising the optically active polymaleimide derivatives and method of separating optically active compounds using them
03/06/2007US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
03/06/2007US7186747 enzyme inhibitors comprising heterocyclic amides, used for prevention of viral diseases
03/06/2007US7186746 Indoles having anti-diabetic activity
03/06/2007US7186745 Angiogenesis inhibitors
03/06/2007US7186744 prostaglandin derivatives such as Acetic acid 2-acetoxy-5-(2-{(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-((E) (S)-3-hydroxy-oct-1-enyl)-cyclopenyl]-hept-5-enoylamino}-ethyl)-phenyl ester, used for therapy of vision defects
03/06/2007US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
03/06/2007US7186742 Benzamide inhibitors of the P2X7 receptor
03/06/2007US7186741 Neurotensin active 2,3,diaryl-pyrazolidine derivatives
03/06/2007US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers
03/06/2007US7186737 Inhibitors of p38
03/06/2007US7186736 Non-nucleoside reverse transcriptase inhibitors; N-[2-(2,5-dimethoxyphenylethyl)]-N'-2-(5-bromopyridyl)]-thiourea and N-[2-(2-fluorophenylethyl)]-N'-[2(5-bromopyridyl)]-thiourea; DDE236 or DDE240 respectively; inhibits virus replication; potency against HIV RT wild-type and drug-resistant mutants
03/06/2007US7186735 Vasodilation; cardiovascular disorders; anticoagulants
03/06/2007US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders
03/06/2007US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/06/2007US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders
03/06/2007US7186731 2-cyanopyrrolidinecarboxamide compound
03/06/2007US7186730 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
1 ... 3852 3853 3854 3855 3856 3857 3858 3859 3860 3861 3862 3863 3864 3865 3866 3867 3868 3869 3870 3871 3872 ... 7860